Vimarsana
Biggest News Aggregation in the World

Page 13 - Drug Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Programs Today - Breaking & Trending Today

Mental Health Campaign Stresses to Kids: It's OK Not to Be OK | Your Health - Vimarsana News

Mental Health Campaign Stresses to Kids: It's OK Not to Be OK | Your Health

The Santa Barbara County Department of Behavioral Wellness worked with local youth in Santa Barbara County for its new campaign — It’s OK not to be OK.

Santa Barbara County launches campaign supporting youth mental health: "It's OK not to be OK" - Vimarsana News

Santa Barbara County launches campaign supporting youth mental health: "It's OK not to be OK"

The county said this campaign will focus on mental health and substance misuse from the perspective of Santa Barbara County youth.

Source: keyt.com
FDA Approves Narcan for Over-the-Counter Use Without Prescription | Local News - Vimarsana News

FDA Approves Narcan for Over-the-Counter Use Without Prescription | Local News

Nasal spray is the first opioid overdose-reversal drug approved by the FDA for sale and use over the counter

Delhi University (DU) admission: CUET mandatory for UG programs - Vimarsana News

Delhi University (DU) admission: CUET mandatory for UG programs

Candidates have been advised to visit the CUET (UG)-23 website for detailed information on eligibility requirements, syllabi of various test papers

ASH 2022 | Ascentage Pharma to Present Data of Olverembatinib (HQP1351) in Three Oral Reports, Including the First Dataset from the First US Study, at the ASH Annual Meeting - Vimarsana News

ASH 2022 | Ascentage Pharma to Present Data of Olverembatinib (HQP1351) in Three Oral Reports, Including the First Dataset from the First US Study, at the ASH Annual Meeting

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...